Biomimetic nanoparticles: Preparation, characterization and biomedical applications

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 249-259

  Carmona Ribeiro, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antigens; Bilayer fragments; Cationic lipid; Drugs; Novel cationic immunoadjuvants; Phospholipids; Polymeric particles; Silica; Vesicles

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CHLORAMBUCIL; CISPLATIN; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DRUG CARRIER; FLUCONAZOLE; IMMUNOLOGICAL ADJUVANT; LATEX; LIPID; LIPOSOME; MACROGOL; MICONAZOLE; MONOMER; NANOCAPSULE; NANOPARTICLE; PHOSPHATIDYLETHANOLAMINE; POLYMER; SILICON DIOXIDE; UNCLASSIFIED DRUG; VACCINE; ZOLTEC;

ADSORPTION; AQUEOUS SOLUTION; BIOMEDICINE; BIOMIMETICS; DRUG FORMULATION; DRUG GRANULE; DRUG SOLUBILITY; HYDROPHOBICITY; LIPID BILAYER; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; REVIEW; TUMOR; VACCINE PRODUCTION;

EID: 77951173603     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/ijn.s9035     Document Type: Review

References (123)

1. El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005;5:829-834.
2. Medintz AR, Clapp JS, Melinger JR, Deschamps H, Mattoussi A. Reagentless Biosensing assembly based on quantum dot-donor Förster resonance energy transfer. Adv Mater. 2005;17:2450-2455.
3. Carmona-Ribeiro AM. Bilayer-forming synthetic lipids: drugs or carriers? Curr Med Chem. 2003;10:2425-2446.
4. O'Hagan DT, Singh M, Ulmer JB. Microparticles for the delivery of DNA vaccines. Immunol Rev. 2004;199:191-200.
5. Caputo A, Sparnacci K, Ensoli B, Tondelli L. Functional Polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines. Curr Drug Delivery. 2008;5:230-242.
6. Moura SP, Carmona-Ribeiro AM. Cationic bilayer fragments on silica at low ionic strength: competitive adsorption and colloid stability. Langmuir. 2003;19:6664-6667.
7. Carmona-Ribeiro AM, Midmore BR. Synthetic bilayer adsorption onto polystyrene microspheres. Langmuir. 1992;8:801-806.
8. Carmona-Ribeiro AM. Biomimetic particles in drug and vaccine delivery. J Liposome Res. 2007;17:165-172.
9. Pereira EMA, Vieira DB, Carmona-Ribeiro AM. Cationic bilayers on polymeric particles: effect of low NaCl concentration on surface coverage. J Phys Chem B. 2004;108:11490-11495.
10. Carmona-Ribeiro AM. Lipid bilayer fragments and disks in drug delivery. Curr Med Chem. 2006;13:1359-1370.
11. Lincopan N. Carmona-Ribeiro AM. Protein assembly onto cationic supported bilayers. J Nanosci Nanotechnol. 2009;9:3578-3586.
12. Lincopan N, Espíndola NM, Vaz AJ, Carmona-Ribeiro AM. Cationic supported lipid bilayers for antigen presentation. In. J Pharm. 2007;340:216-222.
13. Lincopan N, Espíndola NM, Vaz AJ, et al. Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo. Vaccine. 2009;27:5760-5771.
14. Lincopan N, Santana MRA, Faquim-Mauro E, da Costa MHB, Carmona-Ribeiro AM. Silica-based cationic bilayers as immunoadjuvants. BMC Biotechnol. 2009;9:article 5.
15. Vieira DB, Lincopan N, Mamizuka EM, Petri DFS, Carmona-Ribeiro AM. Competitive adsorption of cationic bilayers and chitosan on latex: optimal biocidal action. Langmuir. 2003;19:924-932.
16. Correia FM, Petri DFS, Carmona-Ribeiro AM. Colloid stability of lipid/polyelectrolyte decorated latex. Langmuir. 2004;20:9535-9540.
17. Araujo FP, Petri DFS, Carmona-Ribeiro AM. Colloid stability of sodium dihexadecyl phosphate/poly(diallyldimethylammonium chloride) decorated latex. Langmuir. 2005;21:9495-9501.
18. Rosa H, Petri DFS, Carmona-Ribeiro AM. Interactions between bacteriophage DNA and cationic biomimetic particles. J Phys Chem B. 2008;112:16422-16430.
19. Bangham AD. editor. Liposome Letters. London: Academic Press; 1983. p. 1-405.
20. Kunitake T, Okahata Y, Tamaki K, Kumamaru F, Takayanagi M. Formation of the bilayer membrane from a series of quaternary ammonium salts. Chem Lett. 1977;6:(4):387-390.
21. Hargreaves WR, Deamer DW. Liposomes from ionic, single-chain amphiphiles. Biochemistry. 1978;17(18):3759-3768.
22. Mortara RA, Quina FH. Chaimovich H. Formation of closed vesicles from a simple phosphate diester. Preparation and some properties of vesicles of dihexadecyl phosphate. Biochem Biophys Res Commun. 1978;81:1080-1086.
23. Czarniecki MF, Breslow R. Photochemical probes for model membrane structures. J Am Chem Soc. 1979;101:3675-3676.
24. Suedholter EJR, Engberts JBFN, Hoekstra DJ. Vesicle formation by two novel synthetic amphiphiles carrying micropolarity reporter head groups. J Am Chem Soc. 1980;102:2467-2469.
25. Israelachvili JN, Mitchell DJ, Ninham BW. Theory of self-assembly of lipid bilayers and vesicles. Biochim Biophys Acta. 1977;470:185-201.
26. Carmona-Ribeiro AM, Yoshida LS, Sesso A, Chaimovich H. Permeabilities and stabilities of large dihexadecylphosphate and dioctadecyldi methylammonium chloride vesicles. J Colloid Interface Sci. 1984;100: 433-443.
27. Carmona-Ribeiro AM, Castuma CE, Sesso A, Schreier S. Bilayer structure and stability in dihexadecyl phosphate dispersions. J Phys Chem. 1991;95:5361-5366.
28. Fuhrhop JH, Fritsch D. Bolaamphiphiles form ultrathin, porous and unsymmetric monolayer lipid membranes. Acc Chem Res. 1986;19: 130-137.
29. Segota S, Tezak D. Spontaneous formation of vesicles. Adv Colloid Interface Sci. 2006;121:51-75.
30. Vieira DB, Carmona-Ribeiro AM. Synthetic bilayer fragments for solubilization of amphotericin B. J Colloid Interface Sci. 2001;244: 427-431.
31. Lincopan N, Mamizuka EM, Carmona-Ribeiro AM. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments. J Antimicrob Chemother. 2003;52:412-418.
32. Lincopan N, Mamizuka EM, Carmona-Ribeiro AM. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments. J Antimicrob Chemother. 2005;55:727-734.
33. Pacheco LF, Carmona-Ribeiro AM. Effects of synthetic lipids on solubilization and colloid stability of hydrophobic drugs. J Colloid Interface Sci. 2003;258:146-154.
34. Lincopan N, Carmona-Ribeiro AM. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole. J Antimicrob Chemother. 2006;58: 66-75.
35. Finer EG, Flook AG, Hauser H. Mechanism of sonication of aqueous egg yolk lecithin dispersions and nature of the resultant particles. Biochim Biophys Acta. 1972;260:49-58.
36. Nath A, Atkins WM, Sligar SG. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry. 2007;46:2059-2069.
37. Bayburt TH, Sligar SG. Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc Natl Acad Sci USA. 2002;99:6725-6730.
38. Lyukmanova EN, Shenkarev ZO, Paramonov AS, et al. Lipid-protein nanoscale bilayers: a versatile medium for NMR investigations of membrane proteins and membrane-active peptides. J Am Chem Soc. 2008;130:2140-2141.
39. Hazelbauer GL, Falke JJ, Parkinson JS. Bacterial chemoreceptors: high-performance signaling in networked arrays. 2008;33:9-19.
40. Lawaczeck R, Kainosho M, Chan SI. The formation and annealing of structural defects in lipid bilayer vesicles. Biochim Biophys Acta. 1976; 443:313-330.
41. Almgren M. Mixed micelles and other structures in the solubilization of bilayer lipid membranes by surfactants. Biochim Biophys Acta. 2000;1508:146-163.
42. Johansson E, Engvall C, Arfvidsson M, Lundahl P, Edwards K. Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes. Biophys Chem. 2005;113:183-192.
43. Johansson E, Lundquist A, Zuo S, Edwards K. Nanosized bilayer disks: attractive model membranes for drug partition studies. Biochim Biophys Acta. 2007;1768:1518-1525.
44. Pansu RB, Arrio B, Roncin J, Faure J. Vesicles versus membrane fragments in DODAC suspensions. J Phys Chem. 1990;94:796-801.
45. Andersson M, Hammarstrom L, Edwards K. Effect of bilayer phase transitions on vesicle structure, and its influence on the kinetics of viologen reduction. J Phys Chem. 1995;99(39):14531-14538.
46. Meyer HW, Richter W, Rettig W, Stumpf M. Bilayer fragments and bilayered micelles (bicelles) of dimyristoylphosphatidylglycerol (DMPG) are induced by storage in distilled water at 4°C. Colloids Surf A: Physicochem Eng Aspects. 2001;183-185:495-504.
47. Carmona-Ribeiro AM, Chaimovich H. Preparation and characterization of large dioctadecyldimethylammonium chloride liposomes and comparison with small sonicated vesicles. Biochim Biophys Acta. 1983;733:172-179.
48. Cocquyt J, Olsson U, Olofsson G, van der Meeren P. Temperature quenched DODAB dispersions: fluid and solid state coexistence and complex formation with oppositely charged surfactant. Langmuir. 2004;20:3906-3912.
49. Vieira DB, Pacheco LF, Carmona-Ribeiro AM. Assembly of a model hydrophobic drug into cationic bilayer fragments. J Colloid Interface Sci. 2006;293:240-247.
50. Vieira DB, Carmona-Ribeiro AM. Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro. J Nanobiotechnol. 2008;6:article 6.
51. Carmona-Ribeiro AM. Synthetic amphiphile vesicles. Chem Soc Rev. 1992;21:209-214.
52. Israelachvili JN. Intermolecular and surface forces. 2nd ed. London; Academic Press Limited: 1992.
53. Tsuruta LR, Lessa MM, Carmona-Ribeiro AM. Interactions between dioctadecyldimethylammonium chloride or bromide bilayers in water. Langmuir. 1995;11:2938-2943.
54. Tsuruta LR. Lessa MM. Carmona-Ribeiro AM. Effect of particle size on colloid stability of bilayer-covered polystyrene microspheres. J Colloid Interface Sci. 1995;175:470-475.
55. Tsuruta LR, Carmona-Ribeiro AM. Counterion effects on colloid stability of cationic vesicles and bilayer-covered polystyrene microspheres. J Phys Chem. 1996;100:7130-7134.
56. Rapuano R, Carmona-Ribeiro AM. Physical adsorption of bilayer membranes on silica. J Colloid Interface Sci. 1997;193:104-111.
57. Rapuano R, Carmona-Ribeiro AM. Supported bilayers on silica. J Colloid Interface Sci. 2000;226:299-307.
58. Carmona-Ribeiro AM, Lessa MM. Interactions between bilayer vesicles and latex. Colloids Surf A. 1999;153:355-361.
59. Moura SP, Carmona-Ribeiro AM. Biomimetic particles: optimization of phospholipid bilayer coverage on silica and colloid stabilization. Langmuir. 2005;21:10160-10164.
60. Moura SP, Carmona-Ribeiro AM. Biomimetic particles for isolation and reconstitution of receptor function. Cell Biochem Biophys. 2006;44: 446-452.
61. Moura SP, Carmona-Ribeiro AM. Adsorption behavior of DODAB/ DPPC vesicles on silica. J Colloid Interface Sci. 2007;313:519-526.
62. Horn RG. Direct measurement of the force between two lipid bilayers and observation of their fusion. Biochim Biophys Acta. 1984;778: 224-228.
63. 2+-mediated intermembrane binding. Nature. 1982;296:164-165.
64. Jackson S, Reboiras MD, Lyle IG, Jones MN. Adsorption of phospholipid vesicles on solid surfaces. Faraday Discuss Chem Soc. 1986;81: 291-301.
65. Brian AA, McConnell HM. Allogeneic stimulation of cytotoxic T cells by supported planar membranes. Proc Natl Acad Sci USA. 1984;81: 6159-6163.
66. Tamm LK, McConnell HM. Supported phospholipid bilayers. Biophys J. 1985;47:105-113.
67. Nollert P, Kiefer H, Jaehnig F. Lipid vesicle adsorption versus formation of planar bilayers on solid surfaces. Biophys J. 1995;69:1447-1455.
68. Charitat T, Bellet-Amalric E, Fragneto G, Graner F. Adsorbed and free lipid bilayers at the solid-liquid interface. Eur Phys J B. 1999;8: 583-593.
69. Tápias GN, Sicchierolli SM, Mamizuka EM, Carmona-Ribeiro AM. Interactions between cationic vesicles and Escherichia coli. Langmuir. 1994;10:3461-3465.
70. Martins LMS, Mamizuka EM, Carmona-Ribeiro AM. Cationic vesicles as bactericides. Langmuir. 1997;13:5583-5587.
71. Carmona-Ribeiro AM, Ortis F, Schumacher RI, Armelin MCS. Interactions between cationic vesicles and cultured mammalian cells. Langmuir. 1997;13:2215-2218.
72. Campanhã MTN, Mamizuka EM, Carmona-Ribeiro AM. Interactions between cationic vesicles and Candida albicans. J Phys Chem B. 2001; 105:8230-8236.
73. Campanhã MTN, Mamizuka EM, Carmona-Ribeiro AM. Interactions between cationic liposomes and bacteria: the physical-chemistry of the bactericidal action. J Lipid Res. 1999;40:1495-1500.
74. Gall D. The adjuvant activity of aliphatic nitrogenous bases. Immunology. 1966;11:369-386.
75. Dailey MO, Hunter RL. The role of lipid in the induction of haptenspecific delayed hypersensitivity and contact sensitivity. J Immunol. 1974;112:1526-1534.
76. Hilgers LA, Snippe H, DDA as an immunological adjuvant. Res Immunol. 1992;143:494-503.
77. Tsuruta LR, Quintilio W, Costa MHB, Carmona-Ribeiro AM. Interactions between cationic liposomes and an antigenic protein: the physical chemistry of the immunoadjuvant action. 1997;38:2003-2011.
78. Klinguer-Hamour C, Libon C, Plotnicky-Gilquin H, et al. DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine. Vaccine. 2002;20:2743-2751.
79. Korsholm KS, Agger EM, Foged C, et al. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology. 2007;121:216-226.
80. Gregoriadis G, McCormack B, Obrenovic M, Saffie R, Zadi B, Perrie Y. Vaccine entrapment in liposomes. Methods. 1999;19:156-162.
81. Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm. 2008;364:272-280.
82. O'Hagan DT, Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines. 2003;2:269-283.
83. Xiang SD, Scholzen A, Minigo G, et al. Pathogen recognition and development of particulate vaccines: Does size matter? Methods. 2006;40:1-9.
84. Gupta R. Aluminum compounds as vaccine adjuvants. Adv Drug Delivery Rev. 1998;32:155-172.
85. Jefferson T, Rudin M, Di Pietrantonj C. Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infectious Diseases. 2004;4:84-90.
86. Clements C, Griffiths E, Clements C, Griffiths E. The global impact of vaccines containing aluminium adjuvants. Vaccine. 2002;20: S24-S33.
87. Trollfors B, Bergfors E, Inerot A. Vaccine related itching nodules and hypersensitivity to aluminium. Vaccine. 2005;23:975-976.
88. Lindblad E. Aluminium adjuvants-in retrospect and prospect. Vaccine. 2004;22:3658-3668.
89. Gupta R, Siber G. Adjuvants for human vaccines current status, problems and future prospects. Vaccine. 1995;13:1263-1276.
90. Singh M, Ugozzoli M, Kazzaz J, et al. A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens. Vaccine. 2006;24:1680-1686.
91. Singh M, O'Hagan D. Advances in vaccine adjuvants. Nature Biotechnology. 1999;17:1075-1081.
92. Ott G, Barchfeld G, Chernoff D, Radhakrishnan R, van Hoogevest P, Van Nest G. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm Biotechnol. 1995;6:277-296.
93. Traquina P, Morandi M, Contorni M, Van Nest G. MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates. J Infect Dis. 1996;174:1168-1175.
94. Granoff D, McHugh Y, Raff H, Mokatrin A, Van Nest G. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitis group C oligosaccharide-CRM197 conjugate vaccine. Infect Immun. 1997;65: 1710-1715.
95. Podda A, Del Giudice G. MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile. Expert Rev Vaccines. 2003; 2:197-203.
96. Cusi M. Applications of influenza virosomes as a delivery system. Hum Vaccin. 2006;2:1-7.
97. Glück R, Burri K, Metcalfe I. Adjuvant and antigen delivery properties of virosomes. Curr Drug Deliv. 2005;2:395-400.
98. Huckriede A, Bungener L, Stegmann T, et al. The virosome concept for influenza vaccines. Vaccine. 2005;23:S26-S38.
99. Baldrick P, Richardson D, Wheeler A. Review of L-tyrosine confirming its safe human use as an adjuvant. J Appl Toxicol. 2002;22:333-344.
100. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA. 1993;90:4942-4946.
101. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB. Benacerraf B, Rock KL. Analysis of MHC class II presentation of particulate antigens of B lymphocytes. J Immunol. 1996;156:2809-2818.
102. Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm. 2005;298:315-322.
103. Osaka T, Nakanishi T, Shanmugam S, Takahama S, Zhang H. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids and Surf B: Biointerfaces. 2009;71(2):325-330.
104. Carmona-Ribeiro AM, Vieira DB, Lincopan N. Cationic surfactants and lipids as anti-infective agents. Anti-Infective Agents in Medicinal Chemistry. 2006;5:33-51.
105. Carmona-Ribeiro AM. Bilayer vesicles and liposomes as interface agents. Chem Soc Rev. 2001;30:241-247.
106. Nash T, Allison AC, Harington JS. Physico-chemical properties of silica in relation to its toxicity. Nature. 1966;210:259-261.
107. Catuogno C, Jones MN. The interaction of cationic and anionic vesicles with zinc citrate dispersions. Colloids Surf A. 2000;163:165-176.
108. Cremer PS, Boxer SG. Formation and spreading of lipid bilayers on planar glass supports. J Phys Chem. 1999;103:2554-2559.
109. Sicchierolli SM, Carmona-Ribeiro AM. Incorporation of the cholera toxin receptor in phospholipid-covered polystyrene microspheres. Colloids and Surf B: Biointerfaces. 1995;5:57-64.
110. Sicchierolli SM, Carmona-Ribeiro AM. Biomolecular recognition at phospholipid-covered polystyrene microspheres. J Phys Chem. 1996;100:16771-16775.
111. Hautala JT, Linden MV, Wiedmer SK, et al. Simple coating of capillaries with anionic liposomes in capillary electrophoresis. J Chromatogr A. 2003;1004:81-90.
112. Haratake M, Hidaka S, Ono M, Nakayama M. Preparation of an ion-exchangeable polymer bead wrapped with bilayer membrane structures for high performance liquid chromatography. Anal Chim Acta. 2007;589:76-83.
113. Gulcev MD, Lucy CA. Factors affecting the behavior and effectiveness of phospholipid bilayer coatings for capillary electrophoretic separations of basic proteins. Anal Chem. 2008;80:1806-1812.
114. Al-Jamal WT, Kostarelos K. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine. 2007;2:85-98.
115. Singh R, Tian B, Kostarelos K. Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo. FASEB J. 2008;22:3389-3402.
116. Soo PL, Dunne M, Liu J, Allen C. Nanosized advanced delivery systems as parenteral formulation strategies for hydrophobic anti-cancer drugs. In: Biotechnology: Pharmaceutical Aspects, de Villiers MM. Aramwit P. Kwon GS, editors. Heidelberg: Springer; 2009. p. 349-383.
117. Sharma P, Ganta S, Denny WA, Garg S. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil. Int J Pharm. 2009;367:187-194.
118. Burger KN, Staffhorst RW, de Vijlder HC, et al. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity. Nature Medicine. 2002;8:81-84.
119. Chupin V, de Kroon AIP, de Kruijff B. Molecular architecture of nanocapsules, bilayer-enclosed solid particles of cisplatin. J Am Chem Soc. 2004;126:13816-13821.
120. Velinova MJ, Staffhorst RW, Mulder WJ, et al. Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipids specificity. Biochim Biophys Acta. 2004;1663:135-142.
121. Lasic DD. Sterically stabilized vesicles. Angew Chem Int Ed Engl. 1994;33(17):1685-1683.
122. Johnsson M, Edwards K. Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. Biophys J. 2003;85:3839-3847.
123. Mornet S, Lambert O, Duguet E, Brisson A. The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy. Nano Lett. 2005;5:281-285.